经过评估,转基因小组得出结论,就对人类和动物健康及环境的潜在影响而言,转基因玉米DP202216与其传统对应品种和经过测试的非转基因玉米品种一样安全。部分原文报道如下:
Genetically modified maize DP202216 was developed to co
nfer tolerance to glufosinate-ammonium-co
ntaining herbicides and to provide an opportunity for yield enhancement under field conditions. These properties were achieved by introducing the mo-pat and zmm28 ex
pression cassettes. The molecular characterisation data and bioinformatic analyses do not identify issues requiring food/feed safety assessment. None of the identified differences in the agronomic/phenotypic and compositio
nal characteristics tested between maize DP202216 and its comparator needs further assessment, except for the levels of stearic acid (C18:0), which do not raise nutritio
nal and safety concerns. The GMO Panel does not identify safety co
ncerns regarding the toxicity and allergenicity of the PAT and ZMM28 proteins as expressed in maize DP202216, and finds no evidence that the genetic modification would change the overall allergenicity of maize DP202216. In the co
ntext of this application, the co
nsumption of food and feed from maize DP202216 does not represent a nutritio
nal co
ncern in humans and animals. The GMO Panel co
ncludes that maize DP202216 is as safe as the comparator and non-GM reference varieties tested, and no post-market mo
nitoring of food/feed is co
nsidered necessary. In the case of accidental release of viable maize DP202216 grains into the environment, this would not raise enviro
nmental safety concerns. The post-market enviro
nmental mo
nitoring plan and reporting intervals are in line with the intended uses of maize DP202216. The GMO Panel co
ncludes that maize DP202216 is as safe as its comparator and the tested non-GM reference varieties with respect to potential effects on human and animal health and the environment.
本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@www.sqrdapp.com、/span>